Publication | Open Access
<p>Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma</p>
80
Citations
24
References
2020
Year
These results reveal the promising potential of U2-AuNP as a drug candidate for targeted therapy in GBM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1